Study
Review Responsibility Transfer Form (draft 07/20/10) page
OMB#: 0925 – 0625 Expiry Date: 01/31/2014 Collection of this information is authorized by The Public Health Service Act, Section 411 (42 USC 285a). Rights of your participation in the NCI CIRB is protected by The Privacy Act of 1974. Participation is voluntary, and there are no penalties for not participating or withdrawing from the NCI CIRB at any time. Refusal to participate will not affect your benefits in any way. The information collected will be kept private to the extent provided by law. Names and other identifiers will not appear in any report of the NCI CIRB. Information provided will be combined for all participants and reported as summaries. You are being requested to complete this instrument so that we can conduct activities involved with the operations of NCI CIRB Initiative.
NOTIFICATION TO RESPONDENT OF ESTIMATED BURDEN Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0625). Do not return the completed form to this address.
|
Study Review Responsibility Transfer Form
Submission of this Study Review Responsibility Transfer Form indicates that the CIRB is no longer the IRB responsible for review of this study. This is a two-step process. Step 1 is to complete this form. Step 2 is to confirm the information and submit.
|
|||||||||||||||||||||||||||
Step 2 – Confirmation and Submission
Step 2: Review information on this confirmation page and click “Submit” if information is correct. If changes are required, click “Go Back” and you will be returned to the Study Review Responsibility Transfer Form where you may make changes.
A:
Once you click “Submit”, your browser will
automatically take you back to the Facilitated Review (FR)
Submission Report webpage. B:
You will receive an email from the CIRB Operations Office
confirming receipt of your transfer request.
Study
Number:
CALGB-80303
Study
Title: "A
Randomized Phase III Trial of Gemcitabine Plus Bevacizumab
(NSC #704865 IND# 7921) versus Gemcitabine Plus Placebo in
Patients with Advanced Pancreatic Cancer"
Name
of IRB: Missouri
Baptist Medical Center
Institution’s
FWA Number: FWA00001234
Local
IRB Registration Number: IRB00001234
Study
participants are enrolled at a site covered by this IRB.
IRB
Approval Letter, if applicable: C:\Documents
and Settings\lcovington\Desktop\transcript.doc OR Not
applicable
After
your review, select the appropriate option below:
If
you want to change any information, click on “Go
Back”. [‘Go Back’ Button] OR
If
the information is correct, click the Submit button. You
will receive an email acknowledgement of the submission.
[‘Submit’
Button]
|
||||||||||||||||||||||||||||||||||||||||
|
File Type | application/msword |
File Title | CIRB WebServices IRB Manager CTIS System |
Author | Matthew L. Beyers |
Last Modified By | Brian Campbell |
File Modified | 2013-08-15 |
File Created | 2013-08-15 |